Accessible Version

Science for the Brain
The nation's leading supporter of biomedical research on disorders of the brain and nervous system


Funding Resources

Program Areas
  • Neurogenetics

(help)
Contact us
My privacy

NINDS is part of the
National Institutes of
Health

  Neurogenetics

Scientific Area of Research

Includes identifying the genes that cause neurological disorders. Includes collecting family data and applying molecular genetic methodologies for gene identification. Investigating the molecular mechanisms through which disease genes act. Includes using animal models and in vitro techniques for studying pathways of gene function. Developing gene-based therapeutics for neurological disorders. Includes gene therapy and pharmaceuticals targeted to specific gene products. Investigating the genetic basis of normal neural development and function. Includes genetically-based studies of neuronal patterning, migration, connectivity, and cognitive/behavioral function. Developing resources for neurogenetic research. Includes tissue and information registries, atlases of gene expression and function, and mutagenesis and phenotyping methodologies.

Funding Opportunities

Current Neurogenetics Funding Announcements

Archived Neurogenetics Funding Announcements

Additional Information

Mission Statement
The Human Genetics Resource Center
Neurogenetics Group Personnel

Mission Statement

Genetic methodologies are having a rapidly increasingly impact on studies of the normal and diseased nervous system. To date, more than 200 genes have been identified that cause or contribute to neurological disorders. It is essential that neuroscientists exploit the power of modern molecular genetics and use the information becoming available from sequencing of the human genome. The Neurogenetics Cluster will:

  • promote efforts to identify neurological disease genes.
  • Identifying genes that, when mutated, cause neurological disorders will permit improved diagnosis and ultimately treatment of these disorders. We will coordinate the collection of family data required to identify disease genes, and encourage exploratory research that utilizes this data for gene discovery.

  • promote investigation of the mechanisms by which genetic mutations cause neurological disease.
  • Once disease genes are identified, the challenge is to determine how mutations in these genes lead to disease. We will encourage the development of animal models for studying pathways of gene function, investigating how these pathways are disrupted by genetic alterations, and ultimately for testing therapeutic interventions.

  • develop gene-based therapeutics for neurological disorders.
  • The nervous system presents unique problems for gene therapy and the development of drugs targeted to specific gene products. Among the most pressing are introducing genes across the blood-brain barrier, targeting gene expression to specific brain regions, and promoting sustained gene expression. We will coordinate research in these areas, and promote the identification of molecular targets for pharmacological intervention.

  • develop resources for neurogenetic research.
  • It is critical that recent advances in genetic technology be made widely available to the neuroscientific community. We will promote the development of gene expression maps of the brain, novel mutagenesis and phenotyping strategies, functional genomic methodologies, and more powerful techniques for linkage analysis of multigenic diseases.

  • promote basic research in neurogenetics.
  • Increased knowledge of the genetic basis of neural development and function will provide a foundation for progress in all the areas described above. We will foster research involving the genetic mechanisms that control neural development, including pattern formation, cell migration, axon guidance, and related processes. We will also promote the investigation of the genetic underpinnings of behavior and cognition, including sleep, learning, memory, and emotion.

    The Human Genetics Resource Center: DNA and Cell Line Repository
    The NINDS Human Genetics Resource Center at the Coriell Institute is a growing bank for human cells, DNA samples, clinical data, and information sources, to accelerate research on genetics of disorders of the nervous system. Its mission is to provide genetics support for scientists investigating pathogenesis in the central and peripheral nervous networks and information support for patients, families, and advocates concerned with the living-side of neurological disease and stroke. More...

    Additional Links

    Workshops and Summaries

    Hereditary Dysautonomias: Current Knowledge and Collaborations for the Future October 3 - 4, 2002
    The Mucopolysaccharidoses: Therapeutic Strategies for the Central Nervous System September 24 - 25, 2002
    New Perspectives In Tuberous Sclerosis Complex September 19 - 22, 2002
    Future Research Directions in Joubert Syndrome June 27 - 28, 2002
    First Symposium on Pediatric Neurotransmitter Diseases May 17 - 19, 2002
    Neurology of Disease in Children: Neurofibromatosis October 16, 2001
    The Role of DNA Damage Response Defects in Neurogenetic Diseases: Working Group Meeting July 29 - August 1, 2001
    Workshop on Classification and Definition of Disorders Causing Hypertonia in Childhood April 22-24, 2001
    DMRF/NINDS Dystonia Workshop January 19-21, 2001
    Workshop on Perinatal and Childhood Stroke September 18-19, 2000
    Developmental Cerebral Blood Flow and Metabolism Symposium June 8-11, 2000
    The First Scientific Workshop of Hallervorden-Spatz Syndrome May 19-20, 2000
    Theraputic Approaches for Duchenne Muscular Dystrophy May 15-17, 2000
    The Cause and Treatment of Facioscapulohumeral Muscular Dystrophy May 8-9, 2000
    Defining the Future of Neurofibromatosis Research May 4-5, 2000
    Brain Uptake and Utilization of Fatty Acids: Applications to Peroxisomal Biogenesis Diseases March 2-4, 2000
    The Dopamine Connection Workshop November 10-11, 1999
    Near Infrared Spectroscopy (NIRS) for Infant Cerebral Function Monitoring May 18, 1999
    Batten Disease: Basic Biology and Therapy April 1-2, 1999
    Near Infrared Spectroscopy in Infants and Children September 25-26, 1997

    Personnel

    Robert Finkelstein, Ph.D.
    Program Director
    Email rf45c@nih.gov


       Katrina Gwinn-Hardy, M.D.
    Program Director
    Email kgl27a@nih.gov


    Gabrielle Leblanc, Ph.D.
    Program Director
    Email gl54h@nih.gov


       Laura Mamounas, Ph.D.
    Program Director
    Email lm92t@nih.gov


    Danilo Tagle, Ph.D.
    Program Director
    Email datagle@helix.nih.gov


       Sussan Paydar, Ph.D.
    Program Analyst
    Email sp267q@nih.gov


    Quandra Scudder
    Program Analyst
    Email gs3y@nih.gov


       Tarsha McCrae
    Program Assistant
    Email tm221k@nih.gov


    Tasha Davis
    Program Assistant
    Email td148b@nih.gov

    Address

    Neurogenetics
    6001 Executive Blvd
    Room 2136
    Bethesda, MD 20892
    Phone: (301) 496-5745
    Fax: (301) 402-1501
    For courier service only, use Rockville MD, 20852


    National Institute of Neurological Disorders and Stroke
    Home | About NINDS | Disorders | Funding | News & Events | Find People | Jobs & Training | Accessibility
    H H S Logo - link to U. S. Department of Health and Human Services     N I H logo - link to U. S. National Institutes of Health    N I N D S logo - link to National Institute of Neurological Disorders and Stroke    FirstGov Logo - link To FirstGov